# Immunogenicity of Co-administered Yellow Fever and Measles, Mumps, and Rubella (MMR) Vaccines

> **NCT03368495** · PHASE4 · COMPLETED · sponsor: **Alba Maria Ropero** · enrollment: 851 (actual)

## Conditions studied

- Vaccine Response Impaired

## Interventions

- **BIOLOGICAL:** Co-administration of MMR/YF
- **BIOLOGICAL:** MMR followed by YF
- **BIOLOGICAL:** YF followed by MMR

## Key facts

- **NCT ID:** NCT03368495
- **Lead sponsor:** Alba Maria Ropero
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-23
- **Primary completion:** 2018-06
- **Final completion:** 2018-06-30
- **Target enrollment:** 851 (ACTUAL)
- **Last updated:** 2019-05-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03368495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03368495, "Immunogenicity of Co-administered Yellow Fever and Measles, Mumps, and Rubella (MMR) Vaccines". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03368495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*